Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiyan Luo

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Epigenomics|January 25, 2023
Comprehensive analysis of <i>ESR1</i>-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinomaHuiyan Luo, Qiyin Jiang, Yuehua Luo, et al.
International Immunopharmacology|September 18, 2023
The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella reviewJixin Chen, Shuqi Chen, Huiyan Luo, et al.
Biodata Mining|May 8, 2021
A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinomaQian Yan, Wenjiang Zheng, Boqing Wang, et al.
Frontiers in Pharmacology|February 6, 2023
Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technologyMiaolun Yang, Qian Yan, Yuehua Luo, et al.
Medicine|August 7, 2020
A network meta-analysis: The best Yiqi Fuzheng Chinese herbal injections for use based on the NP regimen to treat NSCLCHuiyan Luo, Wenjiang Zheng, Qian Yan, et al.
Genomics|August 30, 2021
Global analysis of DNA methylation in hepatocellular carcinoma via a whole-genome bisulfite sequencing approachQian Yan, Ying Tang, Fan He, et al.
Nanoscale|May 2, 2025
Correction: Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancerZhe Yang, Huiyan Luo, Zhong Cao, et al.
Nanoscale|May 21, 2016
Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancerZhe Yang, Huiyan Luo, Zhong Cao, et al.
Cancer Chemotherapy and Pharmacology|May 29, 2013
Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapyCui Chen, Fenghua Wang, Zhiqiang Wang, et al.
Journal of Biomedical Nanotechnology|August 22, 2015
Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer CellsZhe Yang, Wenxin Tang, Xingen Luo, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Epigenomics|January 25, 2023
Comprehensive analysis of <i>ESR1</i>-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinomaHuiyan Luo, Qiyin Jiang, Yuehua Luo, et al.
International Immunopharmacology|September 18, 2023
The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella reviewJixin Chen, Shuqi Chen, Huiyan Luo, et al.
Biodata Mining|May 8, 2021
A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinomaQian Yan, Wenjiang Zheng, Boqing Wang, et al.
Frontiers in Pharmacology|February 6, 2023
Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technologyMiaolun Yang, Qian Yan, Yuehua Luo, et al.
Medicine|August 7, 2020
A network meta-analysis: The best Yiqi Fuzheng Chinese herbal injections for use based on the NP regimen to treat NSCLCHuiyan Luo, Wenjiang Zheng, Qian Yan, et al.
Genomics|August 30, 2021
Global analysis of DNA methylation in hepatocellular carcinoma via a whole-genome bisulfite sequencing approachQian Yan, Ying Tang, Fan He, et al.
Nanoscale|May 2, 2025
Correction: Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancerZhe Yang, Huiyan Luo, Zhong Cao, et al.
Nanoscale|May 21, 2016
Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancerZhe Yang, Huiyan Luo, Zhong Cao, et al.
Cancer Chemotherapy and Pharmacology|May 29, 2013
Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapyCui Chen, Fenghua Wang, Zhiqiang Wang, et al.
Journal of Biomedical Nanotechnology|August 22, 2015
Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer CellsZhe Yang, Wenxin Tang, Xingen Luo, et al.
Pageof 6